Microcosting the optimization of PrEP implementation among sexual and gender minority individuals with a substance use disorder.

What was studied

This study counted what it costs to run a program for PrEP care in HIV. The program served sexual and gender minority people with a substance use disorder. It grew out of a trial at a single site. The trial compared support called A.S.K-PrEP with standard care. Some people also got contingency management for drug use. The team listed start-up, time-based and variable costs. Prices came from national averages.

What they found

Start-up costs in the first year were $25,958. Yearly time-based costs were $68,442 across the strategies. For A.S.K-PrEP alone, yearly variable costs were $31,716. They were $31,994 for A.S.K-PrEP plus contingency management. They were $30,271 for contingency management alone. Cost per person was $55 for standard care and $104 for A.S.K-PrEP alone.

What it means for patients

The authors say the study gives real-world cost needs for each strategy. They say the results and a public budget tool may help sites plan. They link this to feasibility and lasting use of PrEP.

Why it is not certain yet

The abstract gives costs, not health results. It does not say which strategy works better. The trial ran at a single site. Costs came from national prices, not from the site's own bills.

Source

Microcosting the optimization of PrEP implementation among sexual and gender minority individuals with a substance use disorder.

We restate facts from the source record in our own words. The original wording belongs to its publisher.